• Apple shares slid Friday after The New York Times reported that the Justice Department is preparing an antitrust lawsuit against the iPhone maker, which could be filed as soon as this year.
• The lawsuit, if it comes to pass, would be the biggest antitrust risk for Apple in years.

Apple shares slid less than 1% on Friday after The New York Times reported that the U.S. Department of Justice is preparing an antitrust lawsuit against the iPhone maker, which could be filed as soon as this year.

The agency's lawsuit could target how the Apple Watch works exclusively with the iPhone, as well as the company's iMessage service, which is also solely available on Apple devices. It could also focus on Apple Pay, the company's payments system, according to the report.

The lawsuit, if it comes to pass, would be the biggest antitrust risk for Apple in years. The U.S. is Apple's largest market, and Apple says the way in which iMessage and the Apple Watch work are essential features that distinguish iPhones from Android phones.

The news comes as investors and analysts have started to fret about the various regulatory risks facing Apple, including new regulations in Europe over the company's App Store's control over iPhone software distribution, as well as a recent Justice Department trial targeting Google's search deals, including its lucrative arrangement with Apple.

"While Apple's share price increased by 48% in 2023, our concerns regarding Apple's legal risks have intensified in recent months," CFRA analyst Nick Rodelli wrote in a note Friday.

Apple CEO Tim Cook will meet with the European Commission's top antitrust enforcer, Margrethe Vestager, next Thursday.

A representative for Apple declined to comment. The Department of Justice did not immediately respond to CNBC's requests for comment.

Don't miss these stories from CNBC PRO:

• These stocks will be the biggest S&P 500 winners of 2024, according to analysts
• Here's where to invest $50,000 in the new year, according to the pros
• Could a bitcoin ETF approval be a sell-the-news event? Here's what to expect if it happens
• These stocks will be the biggest Dow winners of 2024, according to analysts
• Oprah's flip on weight loss drugs is a sign of what's to come for the 'Ozempic trade' in 2024